Advanced cardiovascular-kidney-metabolic syndrome (stage 3/4) is associated with marked reductions in life expectancy among U.S. adults, particularly in Mexican Americans.
Advanced Cardiovascular-Kidney-Metabolic (CKM) syndrome significantly reduces life expectancy, highlighting the critical need for early detection and targeted interventions, especially in high-risk demographic groups.
Absolute Event Rate: 0% vs 0%
Advanced CKM syndrome (stage 3/4) confers marked life expectancy reductions, particularly among Mexican Americans, underscoring the urgent need for early detection and targeted interventions.
MA et al. (Thu,) reported a other. Advanced cardiovascular-kidney-metabolic syndrome (stage 3/4) is associated with marked reductions in life expectancy among U.S. adults, particularly in Mexican Americans.